Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in PRLD — Prelude Therapeutics Inc

CIK 72971 SAN FRANCISCO, CA
Back to PRLD Full portfolio

Position in PRLD

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$134,982
+$134,742 QoQ
Shares Held
25,325
+8426.9% QoQ
Ownership
0.032%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#39
of 75 holders
Holding Since
Dec 2020
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PRLD Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. PRLD ranks #274 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in PRLD

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $134,982 25,325
2025-06-30 $240 297
2025-03-31 $6,076 7,912
2024-12-31 $9,864 7,737
2024-09-30 $12,529 6,053
2024-06-30 $22,067 5,792
2024-03-31 $24,998 5,274
2023-12-31 $19,637 4,599
2023-09-30 $11,235 3,636
2023-06-30 $18,990 4,220
2023-03-31 $1,014 178
2022-12-31 $2,065 342
2022-09-30 $2,450 371
2022-06-30 $976 187
2022-03-31 $690 100
2021-12-31 $39,241 3,152
2021-09-30 $1,343 43
2021-06-30 $1,231 43
2021-03-31 $43,979 1,015
2020-12-31 $343,868 4,806